Awarded contractOpenSuppliesGermany
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Rivaroxaban (ausschließlich FTA), ATC B01AF01 für die Zeit 01.10.2022 - 30.09.2024
1 lot awarded
Buyer: DAK-Gesundheit / Hamburg, Germany
Published Mar 29, 2024Awarded Sep 30, 2022
Pharmaceutical products
Awarded value
Not specified
Estimated value
Not specified
Award date
Sep 30, 2022
Winners
0
Lots awarded
1
Winners
No winners specified.
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0001 | Not specified | — | Pharmaceutical products (33600000) |